Cologne – SDAX-listed INDUS Holding AG has successfully carried out a capital increase amounting to around 10% of its share capital, making partial use of authorised capital. The new shares were placed with institutional investors at a price of EUR 36.40 per share in an accelerated bookbuilding process exempt from a prospectus, with shareholder subscription rights excluded. The gross issuance volume was around EUR 85 million.
A CMS team advised INDUS on all legal aspects of structuring and implementing the capital increase. Commerzbank acted as sole global coordinator for the capital increase.
INDUS Holding AG is a listed private equity firm with an emphasis on long-term development of its portfolio companies. Its industry focus is on construction and infrastructure, automotive technology, engineering, medical engineering and life sciences, and metals technology. In the 2020 financial year, INDUS generated sales of around EUR 1.56 billion. The capital increase provides INDUS with headroom to make further acquisitions in defined sectors with strong future prospects while maintaining stable balance sheet ratios.
CMS Germany
Dr Richard Mayer-Uellner, Lead Partner, Cologne
Dr Petra Schaffner, Lead Partner, Cologne, both Stock Corporation Law
Dr Andreas Zanner, Partner, Frankfurt
Dr Philipp Melzer, Partner, Frankfurt
Jörg Baumgartner, Counsel, Frankfurt, all Capital Markets Law
CMS Austria
Dr Mathias Strasser, Partner, US Capital Markets Law
INDUS
Stephanie Lüdtke (General Counsel)
Press Contact
presse@cms-hs.com
